Overview
Parvovirus B19 is a small, non-enveloped, single-stranded DNA virus and the only member of the Parvoviridae family known to be pathogenic in humans. It is the causative agent of erythema infectiosum, also known as fifth disease or slapped cheek syndrome. Infection is common and widespread, with transmission occurring through respiratory secretions, blood products, and vertical transmission from mother to fetus. The clinical manifestations vary depending on the immunologic and hematologic status of the host. Detection of Parvovirus B19 IgG and IgM antibodies is used to assess exposure, immunity, and recent infection.
Symptoms
Initial symptoms are usually mild and flu-like, including fever, malaise, and headache. In children, infection commonly presents with a bright red rash on the cheeks followed by a lacy rash on the limbs and trunk. Adults may develop arthralgia or arthritis, particularly women. In individuals with hemolytic disorders, infection can cause transient aplastic crisis. Pregnant women may be asymptomatic but are at risk of fetal complications such as severe anemia, hydrops fetalis, miscarriage, or stillbirth. Immunocompromised individuals may develop chronic infection with persistent anemia.
Causes
Parvovirus B19 infection is caused by exposure to the virus through inhalation of respiratory droplets, contact with infected blood or blood products, percutaneous exposure, or transplacental transmission during pregnancy. The virus targets erythroid precursor cells in the bone marrow, temporarily suppressing red blood cell production. A positive IgM antibody indicates recent infection or reinfection, while a positive IgG antibody indicates past infection and immunity.
Risk Factors
Children in schools or daycare settings, household contacts of infected individuals, and healthcare workers are at increased risk due to close contact and respiratory spread. Pregnant women, especially during the first half of pregnancy, are at higher risk of fetal complications if infected. Individuals with chronic hemolytic anemia, immunosuppression, HIV infection, or those undergoing organ transplantation are more susceptible to severe or persistent disease. Exposure through blood transfusion or occupational needle-stick injuries also increases risk.
Prevention
There is no vaccine or specific antiviral treatment available for Parvovirus B19 infection. Prevention relies on routine infection control measures such as frequent handwashing, covering the mouth and nose while coughing or sneezing, and avoiding close contact with infected individuals when possible. In healthcare and household settings, adherence to hygiene practices helps reduce transmission. Pregnant women with known exposure should undergo appropriate serological testing and monitoring to reduce the risk of adverse fetal outcomes.
